z-logo
open-access-imgOpen Access
[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
Author(s) -
Dexuan Ma,
Shanqing Li,
Yuming Cui,
Li Li,
Huan Liu,
Yeye Chen,
Xin Zhou
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12480
Subject(s) - oncogene , paclitaxel , pi3k/akt/mtor pathway , cancer , molecular medicine , protein kinase b , cell cycle , cancer research , lung cancer , apoptosis , cell , sensitivity (control systems) , medicine , chemistry , oncology , biochemistry , engineering , electronic engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here